Diseases, Conditions, Syndromes

A new COVID booster is here. Will those at greatest risk get it?

The Centers for Disease Control and Prevention recommends new COVID-19 booster vaccines for all—but many who need them most won't get them. About 75% of people in the United States appear to have skipped last year's bivalent ...

Neuroscience

Guidance on new treatments for early Alzheimer's disease issued

New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease. To help neurologists discuss these ...

page 12 from 40